XERS
Xeris Pharmaceuticals Inc
Price:  
9.08 
USD
Volume:  
1,375,715.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

XERS Stock Forecast & Price Target

XERS Stock Price Forecast

The average stock forecast for Xeris Pharmaceuticals Inc (XERS) in the next 12 months is 12.65 USD. This price target corresponds to an upside of 47.24%. The range of stock forecasts for XERS is 8.08 - 18.90 USD. Based on the ratings of 13 analysts, the consensus recommendation for XERS is BUY.
Target Low Average Median High
Price (USD) 8.08 12.65 12.24 18.90
Upside -5.94% 47.24% 42.49% 120.02%

Recommendation Trends

The latest consensus rating for XERS is "BUY". This is the average recommendation of 13 analysts: 0 strong sell, 0 sell, 2 hold, 6 buy, 5 strong buy. In the previous period, 13 analysts also majorly recommmended "BUY" for XERS.

XERS Financial Stock Forecast

Revenue This Year
395.15M
35.40%
from 291.85M
Revenue Next Year
490.94M
24.24%
from 395.15M
EPS This Year
0.02
408.57%
from 0.00
EPS Next Year
0.33
1,952.06%
from 0.02